Proxy Votes Now

Home › Funds › Vanguard › Equity Income Portfolio

Equity Income Portfolio proxy voting record 2025-2026

Fund family: Vanguard · Filed by VANGUARD VARIABLE INSURANCE FUNDS (CIK 857490) · SEC series S000004399

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,493 with, 139 against, 0 abstentions (not counted as with management). Shareholder proposals: 7 FOR, 128 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Vanguard as a whole

The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsVanguardItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)99.2%2,42494.5%1,082,514
Backed environmental and social shareholder proposals at US companies0.0%590.9%6,718

Where this fund voted differently from most Vanguard funds

Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Vanguard funds on 19 items (0.7% of the 2,592 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Vanguard fundsMgmtResult
The Progressive Corporation2026-05-08Election of Directors: Lawton W. FittAgainstFOR — 31 of 33 Vanguard fundsForElected, 85.8% support
L3Harris Technologies, Inc.2026-05-11Shareholder Shareholder Proposal titled "Improve Shareholder Ability to Call for a Special Shareholder Meeting".ForAGAINST — 24 of 26 Vanguard fundsAgainst—
Zoetis Inc.2026-05-20Shareholder Shareholder proposal to permit shareholder action by written consent.ForAGAINST — 24 of 26 Vanguard fundsFor—
American International Group, Inc.2026-05-13Advisory Vote to Approve Named Executive Officer Compensation.AgainstFOR — 32 of 36 Vanguard fundsForPassed (calculated), 77.5% support
American International Group, Inc.2026-05-13Election of Directors: DIANA M. MURPHYAgainstFOR — 28 of 31 Vanguard fundsForElected, 91.2% support
American International Group, Inc.2026-05-13Election of Directors: JUAN R. PEREZAgainstFOR — 28 of 31 Vanguard fundsForElected, 91.9% support
American International Group, Inc.2026-05-13Election of Directors: LINDA A. MILLSAgainstFOR — 28 of 31 Vanguard fundsForElected, 88.9% support
Pfizer Inc.2026-04-23Shareholder Adopt an Independent Chair PolicyForAGAINST — 25 of 28 Vanguard fundsForNot approved, 28.8% support
Regions Financial Corporation2026-05-06Shareholder Shareholder Proposal Relating to Special Shareholder Meeting.ForAGAINST — 24 of 27 Vanguard fundsAgainstNot approved, 43.9% support
Accenture Plc2026-01-28To approve, in a non-binding vote, the compensation of our named executive officers.AgainstFOR — 33 of 40 Vanguard fundsFor—
Ares Management Corporation2026-06-08Election of Directors: Antoinette BushForAGAINST — 20 of 23 Vanguard fundsForElected, 94.3% support
Ares Management Corporation2026-06-08Election of Directors: Antony P. ResslerForAGAINST — 20 of 23 Vanguard fundsForElected, 92.5% support
Ares Management Corporation2026-06-08Election of Directors: Dr. Judy D. OlianForAGAINST — 20 of 23 Vanguard fundsForElected, 92.4% support
Ares Management Corporation2026-06-08Election of Directors: Michael J AroughetiForAGAINST — 20 of 23 Vanguard fundsForElected, 93.9% support
Eaton Corporation plc2026-04-22Election of Directors: Gregory R. PageAgainstFOR — 11 of 13 Vanguard fundsAgainst—
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.ForAGAINST — 27 of 37 Vanguard fundsAgainstNot approved, 33.7% support
NXP Semiconductors N.V.2026-06-10Appoint Gregory Summe as non-executive directorAgainstFOR — 10 of 14 Vanguard fundsAgainstPassed (calculated), 85.9% support
NXP Semiconductors N.V.2026-06-10Appoint Karl-Henrik Sundstrom as non-executive directorAgainstFOR — 10 of 14 Vanguard fundsAgainstPassed (calculated), 92.5% support
AstraZeneca plc2026-04-09Elect Marcus WallenbergAgainstFOR — 4 of 7 Vanguard fundsAgainst—

Download all 19 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 93.4% of this fund’s 2,632 such votes could be given a sector; the other 174 (6.6%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance578305.2%
Consumer Discretionary395348.6%
Utilities27093.3%
Industrials267124.5%
Health Care246166.5%
Technology244124.9%
Energy14864.1%
Consumer Staples139139.4%
Telecommunications9977.1%
Miscellaneous3700.0%
Real Estate3500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,9124
Audit-related1930
Say-on-Pay1812
Corporate Governance12764
Compensation813
Capital Structure550
Environment or Climate3029
Other Social Issues2321
Shareholder Rights and Defenses156
Extraordinary Transactions101

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Broadcom Inc.April 20, 2026$4.4B120
Merck & Co., Inc.May 26, 2026$3.1B193
Johnson & JohnsonApril 23, 2026$2.5B151
Bank of America CorporationMay 4, 2026$2.1B282
Cisco Systems, Inc.December 16, 2025$2.1B251
Keurig Dr Pepper Inc.June 16, 2026$2.0B120
Diamondback Energy, Inc.May 20, 2026$1.8B160
Marsh & McLennan Companies, Inc.May 21, 2026$1.5B170

Notable votes against management

MeetingCompanyProposalFundMgmt
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
May 4, 2026Bank of America CorporationShareholder proposal requesting independent board chair Shareholder proposalAgainstFor
May 4, 2026Bank of America CorporationShareholder proposal requesting report on board oversight of risks related to animal welfare Shareholder proposalAgainstFor
December 16, 2025Cisco Systems, Inc.Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders. Shareholder proposalAgainstFor
May 22, 2026Honeywell International Inc.Shareowner Proposal - Shareholder Right to Act by Written Consent. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 6, 2026Philip Morris International Inc.Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposalAgainstFor
May 13, 2026Elevance Health, Inc.Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposalAgainstFor
May 5, 2026Dominion Energy, Inc.Shareholder Proposal Regarding a Policy for an Independent Chair Shareholder proposalAgainstFor

Search this fund’s votes by company

2,636 ballot items at 193 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Equity Income Portfolio voted at 193 shareholder meetings of 182 companies, on 2,636 ballot items in all. Where management made a recommendation, the fund followed it on 94.7% of the items and voted against it 139 times. Its most frequent area of disagreement was corporate governance (64 of its votes against management). It voted FOR 5.2% of the 135 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (99.2% against 94.5%). It voted differently from most Vanguard funds on 19 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.